Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse Anti-Human IgG2 Fd-AF555 (HP6014)

Cat. No.:
9080-32
Alexa Fluor® 555 Anti-Human IgG2 Fd antibody for use in mmunohistochemistry and western blotting assays.
$289.00
Size Price (USD) Quantity
0.1 mg $289.00
More Information
Clone HP6014
Isotype Mouse (BALB/c) IgG1κ
Isotype Control 0102-32
Specificity Human IgG2 Fd
Immunogen Human IgG2 myeloma protein
Conjugate AF555 (Alexa Fluor® 555)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Monoclonal
Concentration 0.5 mg/mL
Volume 0.2 mL
Recommended Storage 2-8°C; Avoid exposure to light
Trademark Information Alexa Fluor® is a registered trademark of Thermo Fisher Scientific, Inc. or its subsidiaries
Applications ELISA – Quality tested 2-12
FLISA – Quality tested
Flow Cytometry – Reported in literature 19
Immunohistochemistry-Frozen Sections – Reported in literature 13-15
Immunohistochemistry-Paraffin Sections – Reported in literature 12,16,17
Western Blot – Reported in literature 13,18,19
Immunoprecipitation – Reported in literature 1
Purification – Reported in literature 19
Depletion – Reported in literature 20

RRID Number AB_2895841
Gene ID 3501 (Human)
Gene ID Symbol IGHG2 (Human)
UniProt ID P01859 (Human)
UniProt Name IGHG2_HUMAN (Human)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Reimer CB, Phillips DJ, Aloisio CH, Moore DD, Galland GG, Wells TW, et al. Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma. 1984;3:263-75. (Immunogen, IP)
  2. 2. Cui Z, Wang H, Zhao M. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69:894-9. (ELISA)
  3. 3. Gao Y, Ye H, Yu F, Guo X, Zhao M. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin Immunol. 2005;117:87-93. (ELISA)
  4. 4. Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol. 2005;139:542-50. (ELISA)
  5. 5. Liu L, Chen M, Yu F, Zhao M, Wang H. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Nephrology. 2008;13:629-35. (ELISA)
  6. 6. Xie L, Gao Y, Li M, Lu G, Guo X. Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status. Clin Exp Immunol. 2008;154:172-6. (ELISA)
  7. 7. Zhao J, Yan Y, Cui Z, Yang R, Zhao M. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHα3(IV)NC1 is associated with disease severity. Hum Immunol. 2009;70:425-9. (ELISA)
  8. 8. Xu P, Chen M, Cui Z, Zhao M. Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis. Rheumatology. 2010;49:2068-75. (ELISA)
  9. 9. Xu P, Cui Z, Chen M, Hellmark T, Zhao M. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology. 2011;50:1236-43. (ELISA)
  10. 10. Xu P, Chen M, Zhao M. High potential to reverse the inhibition of myeloperoxidase by ceruloplasmin of anti-myeloperoxidase autoantibodies of IgG3 subclass. Autoimmunity. 2012;45:218-25. (ELISA)
  11. 11. Shao C, Huo N, Zhao L, Gao Y, Fan X, Zheng Y, et al. The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients. Eur J Endocrinol. 2013;168:717-22. (ELISA)
  12. 12. Jia M, Hu S, Chen J, Qu Z, Liu G, Cui Z, et al. The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int. 2014;85:945-52. (ELISA, IHC-PS)
  13. 13. Mongan LC, Ockleford CD. Behaviour of two IgG subclasses in transport of immunoglobulin across the human placenta. J Anat. 1996;188:43-51. (IHC-FS, WB)
  14. 14. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12:1482-92. (IHC-FS)
  15. 15. Greenlee JE, Boyden JW, Pingree M, Brashear HR, Clawson SA, Keeney PM. Antibody types and IgG subclasses in paraneoplastic neurological syndromes. J Neurol Sci. 2001;184:131-7. (IHC-FS)
  16. 16. Qu Z, Liu G, Li J, Wu L, Tan Y, Zheng X, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27:1931-7. (IHC-PS)
  17. 17. Qu Z, Cui Z, Liu G, Zhao M. The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease. BMC Immunol. 2013;14:19. (IHC-PS)
  18. 18. Harada S, Hata S, Kosada Y, Kondo E. Identification of epitopes recognized by a panel of six anti-human IgG2 monoclonal antibodies. J Immunol Methods. 1991;141:89-96. (WB)
  19. 19. Keen J, Serghides L, Ayi K, Patel SN, Ayisi J, van Eijk A, et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. 2007;4(5):e181. (WB, FC, Purification)
  20. 20. Forthal DN, Landucci G, Ding H, Kappes JC, Wang A, Thung I, et al. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation. AIDS. 2011;25:2099-104. (Depletion)
See All References